Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-05-15

Clinical Trial Update: Effect of Dexmedetomidine on Stress Study of Pituitrin in Laparoscopic Hysteromyoma Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the effect of dexmedetomidine on stress response during Pituitrin-assisted laparoscopic surgery for uterine fibroids.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)
  • Pituitrin (vasopressin and oxytocin)

Snippet

Sponsor: Beijing Anzhen Hospital | Conditions: Hysteromyoma | Phase 3 | Status: UNKNOWN